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Each year in the United States, infections by methi-
cillin-resistant Staphylococcus aureus (MRSA) are
responsible for 19,000 deaths and result in $3–$4
billion of health care costs. Because skin coloniza-
tion is amajor risk factor for S. aureus infection, iden-
tifying novel small molecules produced by S. aureus
can lead to new molecular insights into its ability
to colonize and infect the host and new targets
for antibacterial intervention. Here, we report that a
nonribosomal peptide synthetase conserved across
S. aureus and other skin-associated staphylococci
encodes a family of three pyrazinone natural prod-
ucts. Thesemolecules likely result from the synthesis
and release of a dipeptide aldehyde, its spontaneous
cyclization to a dihydropyrazinone, and subsequent
oxidation to a pyrazinone. As an unexpected family
of small molecule natural products from the path-
ogen S. aureus, the pyrazinones may open a new
window into the interspecies interactions that
underlie the poorly understood process of skin colo-
nization.
INTRODUCTION
Each year in the United States, infections by methicillin-resistant
Staphylococcus aureus (MRSA) are responsible for 19,000
deaths (Klevens et al., 2007) and result in billions of dollars of
health care costs (Klein et al., 2007). A major risk factor for
S. aureus infection is skin colonization (von Eiff et al., 2001).
Although 20% of people are consistently colonized by
S. aureus and 60% are intermittently colonized (Kluytmans
et al., 1997), the molecular factors that determine whether an
individual is colonized are unknown. One set of factors likely
to contribute to colonization state are molecular interactions
among skin-associated bacteria and between these bacteria
and the host. As a component of our effort to characterize small
molecules from the human microflora, we set out to identify
new small molecules produced by S. aureus that might play
a role in colonization-related interspecies interactions.Chemistry & Biology 17, 925–9S. aureus produces siderophores (Beasley et al., 2009; Cotton
et al., 2009) and the glycosylated terpenoid virulence factor
staphyloxanthin (Pelz et al., 2005), but staphylococci are not
otherwise known to produce diffusible small molecule natural
products. From a bioinformatic search for biosynthetic gene
clusters in the genomes of human-associated bacteria, we
were intrigued to find an uncharacterized gene cluster that is
conserved across all sequenced strains of S. aureus and two
other skin-associated species, Staphylococcus epidermidis
and Staphylococcus capitis, but is not found in other sequenced
staphylococci.
Here, we report that this uncharacterized nonribosomal
peptide gene cluster encodes a family of three pyrazinone
natural products. One of these molecules, phevalin, was previ-
ously discovered from a soil actinomycete and shown to harbor
protease inhibitory activity (Alvarez et al., 1995). The other two,
tyrvalin and leuvalin, are new molecules. While our manuscript
was under review, Magarvey and coworkers published an article
reporting similar findings and extending them by showing
that these small molecules regulate S. aureus virulence factor
expression and are necessary for a productive infection in a
mouse model of S. aureus bacteremia (Wyatt et al., 2010).RESULTS AND DISCUSSION
Bioinformatic Analysis of the pzn Gene Cluster
Our bioinformatic search revealed that all sequenced strains of
S. aureus harbor an uncharacterized biosynthetic gene cluster
putatively encoding a nonribosomal peptide synthetase (NRPS)
(Fischbach and Walsh, 2006), here termed pzn. Further bioinfor-
matic analyses suggest that the first gene, pznA, encodes a two-
module NRPS in which the first adenylation (A) domain is pre-
dicted to insert Val whereas the second is selective for Phe or
Tyr. Other two-module NRPSs including the thaxtomin (Loria
et al., 2008) and lyngbyatoxin (Edwards and Gerwick, 2004) syn-
thetases are known to produce modified dipeptides. Interest-
ingly, PznA harbors a C-terminal reductase (R) domain in place
of the more common thioesterase domain, indicating a 2-elec-
tron or 4-electron mode of reductive chain release (Walsh and
Fischbach, 2010), as has been observed previously in bacterial
(Li et al., 2008; Read andWalsh, 2007) and fungal (Liu andWalsh,
2009) NRPS enzymes. We therefore predicted that PznA would
synthesize a dipeptide alcohol or aldehyde. pznB encodes a30, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 925
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Figure 1. Schematic of the S. aureus Pyrazi-
none (pzn) Gene Cluster and Proposed
Biosynthetic Pathway for the Staphylo-
coccus Pyrazinones
A: adenylation domain; C: condensation domain;
T: thiolation domain; R: reductase domain.
Chemistry & Biology
New Pyrazinone Natural Products from S. aureus40-phosphopantetheinyltransferase (Lambalot et al., 1996),
which likely catalyzes the posttranslational priming of both
thiolation domains in PznA (Figure 1). Bioinformatic analyses of
the genes flanking pznA and pznB predict functions unrelated
to small molecule synthesis, regulation, or transport, suggesting
that pznAB is a self-contained two-gene cluster. The pzn gene
cluster is found in all sequenced strains of S. aureus, S. epider-
midis, S. capitis, and Staphylococcus lugdunensis, but not in
other sequenced Staphylococcus species.
Production and Characterization of a pzn
Knockout Strain
To identify the product of the pzn gene cluster, we used an
allelic replacement strategy (Arnaud et al., 2004) to generate
a DpznA mutant of S. aureus RN4220 (Figure 2). Comparative
LC-MS analysis of culture extracts from the wild-type and
DpznA strains revealed three peaks that were present in the
wild-type extract but not the mutant extract (Figure 3). The
peaks showed similar ultraviolet/visible (UV/Vis) absorption
spectra with three maxima at 204, 229, and 325 nm (Figure 3,
inset B). Identical peaks were present in culture extracts from
two S. epidermidis strains that harbor the pzn gene cluster,
American Type Culture Collection (ATCC) 12228 and ATCC
35984, but not Staphylococcus saprophyticus S-41, which
does not harbor the pzn cluster (Figure 3). Growth curves of
the wild-type and DpznA strains were comparable, suggesting
that cell growth and viability are not directly affected by the
loss of the pzn gene cluster (data not shown). The time course
of the phevalin production (Figure 3, inset A) links the biosyn-
thetic activity of the pzn-encoded enzymes to the time period
between 24 and 48 hr of batch cultivation, which corresponds
to the stationary growth phase under the culture conditions
we used for small molecule production.926 Chemistry & Biology 17, 925–930, September 24, 2010 ª2010 Elsevier Ltd All rights reseIsolation and Structure Elucidation
of the Staphylococcus pyrazinones
We cultured S. aureus in a minimal
medium, modified MSgg (Branda et al.,
2001), and purified multimilligram quanti-
ties of each compound by preparative
HPLC; the yields of each compound
were 1 mg/L for phevalin and tyrvalin and
0.3mg/L for leuvalin. Using a combination
of high-resolution mass spectrometry
(MS) and two-dimensional nuclear mag-
netic resonance (2D NMR) experiments
(Table 1; see Table S1 and Figures S1–
S4 available online), the pzn-encoded
natural products were determined to be
a family of three pyrazinones—tyrvalin (1),
phevalin (2), and leuvalin (3)—that differin the identity of one of their constituent amino acid side
chains (Figure 1; Figures S1–S4). Interestingly, 2 was previously
isolated from Streptomyces sp. SC433, a free-living bacterium
unrelated to Staphylococcus that was obtained from a soil
sample collected in Taiwan (Alvarez et al., 1995). 1 and 3 have
not previously been described. To directly compare the chemical
structure of 2 to the reported compound its 1H-NMR spectrum
was recorded under comparable experimental conditions using
CDCl3, as described by Alvarez et al. (1995) (Table S2).
The structures of 1–3 are consistent with the proposed biosyn-
thetic scheme shown in Figure 1. It is often possible to predict
the structure and biosynthetic route of the small molecule
product of an NRPS from the order of its constituent domains
(Fischbach and Walsh, 2006). Our bioinformatic analysis of the
domain structure of PznA is consistent with the following pre-
dicted pathway: the two NRPSmodules of PznA would generate
a nascent dipeptide, which would undergo two-electron reduc-
tive release by the R domain. The C-terminal aldehyde would
likely condense with the N-terminal amino group spontaneously,
yielding a 6-membered dihydropyrazinone intermediate that
would undergo a two-electron oxidation to become 1–3 (Fig-
ure 1). Given the absence of additional oxidoreductase-encod-
ing genes in the pzn gene cluster, we presume that this final
2-electron oxidation is either spontaneous (assisted by the
driving force of aromatization) or is catalyzed by the PznA R
domain operating in reverse as an oxidoreductase/dehydroge-
nase. However, we cannot rule out the participation of an
oxidase encoded elsewhere in the genome.
Insights into Staphylococcus Pyrazinone Biosynthesis
from Feeding Studies
S. aureus produces 1 and 2 in a 1:1 ratio, with 3 as a minor
product (Figure 3). Although the production of low-level siderved
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Figure 2. Strategy for the Allelic Replacement of pznA in S. aureus RN4220
After integration of the plasmid by the first genomic crossover event, the second crossover can either lead to the desired knockout strain or reversion to the wild-
type strain. Successful allelic replacement is demonstrated by Southern blot. Wt corresponds to the wild-type strain of S. aureus RN4220. Ko#1 and #2 corre-
spond to independently generated and selected knockout strains for the NRPS gene pznA. Scheme adapted from Horsburgh et al. (1999).
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major products is unusual, so we investigated their biosynthetic
origins. Such amixture of products could derive from the relaxed
substrate specificity of the second adenylation domain in PznA,
or it could result from the partial post-release hydroxylation of 2
to 1 by an unidentified oxygenase. To distinguish between these
possibilities, we carried out feeding experiments with 2H-labeled
amino acids to track their incorporation into 1–3. Supplementa-
tion of modified MSgg and subsequent LC-MS analysis of
culture extracts revealed roughly equivalent levels of incorpora-
tion of [ring-D5]-L-phenylalanine and [ring-3,5-D2]-L-tyrosine,
supporting A domain promiscuity as the explanation for the
coproduction of 1 and 2. Interestingly, S. epidermidis ATCC
35984 produces more 1 than 2, suggesting that the degree of
PznA-A2 promiscuity may vary between species of Staphylo-
coccus. A domain promiscuity could also explain the fact that
3 is produced at a lower level than 1 and 2, because Leu would
presumably be accepted at lower efficiency than Phe and Tyr.
Initial Efforts to Characterize the Biological Activities
of the Staphylococcus Pyrazinones
As cyclized dipeptide natural products, 1–3 are relatives of
diketopiperazines (DKPs), a large and diverse family of naturalChemistry & Biology 17, 925–9products with a wide range of biological activities (Holden
et al., 1999; Niku-Paavola et al., 1999; Strom et al., 2002).
Because many DKPs, including the structurally related (but
biosynthetically unrelated) molecule albonoursin, (Lautru et al.,
2002) have antibacterial activity, we assayed 1 against Escher-
ichia coli, Bacillus subtilis, and the skin-associated actinomy-
cetes Propionibacterium acnes, Corynebacterium accolens,
Corynebacterium jeikeium, and Corynebacterium urealyticum.
However, we observed no growth inhibition, suggesting that
the Staphylococcus pyrazinones have a distinct activity. The
recent report from Magarvey and coworkers suggests that
these compounds play a role in regulating S. aureus virulence
factor expression (Wyatt et al., 2010). Notably, 2 was originally
isolated from a screen for calpain inhibitors (Alvarez et al.,
1995), indicating that one of the biologically relevant activities
of 1–3 could be protease inhibition. However, the modest
activity of 2 against calpain (IC50 = 1.3 mm) suggests that if 2
is indeed a protease inhibitor, its primary target may be
a different protease. Given that the pzn gene cluster is only
found in skin-associated staphylococci and host proteases
play an important role in the skin barrier function (Leyvraz
et al., 2005), characterizing the protease inhibitory activity of
the Staphylococcus pyrazinones will be one starting point for30, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 927
NH
N
O
OH
tyrvalin
N
H
N
O
leuvalin
N
H
N
O
phevalin
18min 44min
S. aureus RN4220wt
S. aureus RN4220ko
S. saprophyticus S-41 
S. epidermidis ATCC12228
S. epidermidis ATCC35984
24 h
48 h
72 h
200 nm 400 nm
A
B
90 h
Figure 3. Comparison of Pyrazinone Production across Staphylococcus Species
RP-HPLC analysis (325 nm) of methanol extracts of culture supernatants after 48 hr are shown. RN42220ko corresponds to the DpznA S. aureus strain. Both
S. epidermidis strains harbor the pzn gene cluster, whereas S. saprophyticus S-41 does not. Inset A: Time course for the production of phevalin by S. aureus
RN4220wt. Inset B: Ultraviolet/visible absorption spectrum of phevalin.
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related interspecies interactions.SIGNIFICANCE
Our results demonstrate the power of genome mining
(Challis, 2008; McAlpine, 2009) for the discovery of natural
products from human-associated bacteria. Using this
approach, we identified an NRPS-encoding gene cluster
conserved across all sequenced S. aureus strains. A combi-
nation of bacterial genetics and chemical analysis revealed
that this gene cluster encodes three pyrazinone natural
products, one of which was previously discovered from
a soil actinomycete and characterized as a protease
inhibitor, whereas the others are novel molecules. These
molecules do not have detectable antibacterial activity;Table 1. Biosynthetic Incorporation of Isotopically-Labeled Amino A
Compound Calculated Mass HR-MS L-Val (D8)a
Tyrvalin (1) 245.1285 245.1234 252.4 (+7)
Phevalin (2) 229.1335 229.1329 236.4 (+7)
Leuvalin (3) 195.1497 195.1490 202.4 (+7)
HR-MS: High resolution mass spectra. Incorporation of amino acid precurs
transform mass spectrometry and the theoretical masses were calculated b
of mass caused by the corresponding deuterated amino acid. All results
mode and represent (M + H)+.
aa-Carbon labeling, proton lost during aromatization.
928 Chemistry & Biology 17, 925–930, September 24, 2010 ª2010 Eldiscovering the biological activities of these molecules
could lend insights into the role of chemical interactions
between S. aureus and the host—or other skin microbes—
in the process of skin colonization.
EXPERIMENTAL PROCEDURES
Production and Characterization of S. aureus Knockout Strain
Plasmid pMAD was used to construct the DpznA strain of S. aureus as previ-
ously described (Arnaud et al., 2004). Genomic DNA of S. aureus strain
RN4220 was isolated by phenol/chloroform extraction. Briefly, tryptic soy
broth (TSB; Difco) was inoculated 1:100 with an overnight culture of S. aureus
RN4220 in the same culture medium. After 5 hr of incubation at 37C with
shaking at 220 rpm, bacterial cells were pelleted from a 5 ml culture aliquot
and incubated in 700 ml lysis buffer (50 mM EDTA, pH 8; 100mMNaCl) supple-
mented with 0.3 mg/mL RNase A (Invitrogen), 2.5 mg/mL lysozyme from
chicken egg white (Sigma), and 0.2 mg/mL proteinase K (Invitrogen). After
incubating for 10 min at 37C, 0.15 volumes of sodium N-lauroylsarcosinecids
L-Tyr (Ring-3,5-D2) L-Phe (Ring-D5) L-Leu (5,5,5-D3)
247.4 (+2)
234.4 (+5)
198.4 (+3)
ors into Staphylococcus pyrazinones. HR-MS were recorded by Fourier
ased on the molecular formula. The values in brackets indicate the gain
are indicated in daltons. All values were recorded in positive ionization
sevier Ltd All rights reserved
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New Pyrazinone Natural Products from S. aureus(20%) (Sigma) were added and two phenol/chloroform extractions were
carried out followed by an ethanol precipitation of the DNA after acidification
with 0.1 volumes of sodium acetate (3 M, pH 5.5).
DNA fragments corresponding to the 30 and 50 region of pznA (nt: 9–1005
and 6136–7130, respectively) were polymerase chain reaction (PCR)-amplified
using Taq polymerase (Roche) with the primer pairs MZ-021/022 andMZ-023/
024, respectively (Table S3). After treatment with the restriction enzymes (NEB)
indicated in Table S3, the two fragments were sequentially inserted into pMAD
between the restriction sites BamHI/EcoRI and EcoRI/BglII, respectively.
Finally, a 1.3 kb DNA fragment bearing the spectinomycin resistance gene
was amplified from plasmid pKM079 (provided by David Rudner, Harvard
Medical School) with the primer pair MZ-019/020 (Table S3) and introduced
into EcoRI between the two fragments of pznA (Figure 2).
Allelic replacement was verified by PCR amplification of the crossover junc-
tions (primer pairs MZ-019/034 and MZ-032/033; Table S3), confirmation of
susceptibility to erythromycin and resistance to spectinomycin, blue-white
screening (b-galactosidase assay with bromo-chloro-indolyl-galactopyrano-
side), and Southern blotting.
For Southern blotting, genomic DNA of S. aureus RN4220wt, RN4220ko#1
and RN4220ko#2 (two independently generated knockout strains) was iso-
lated as described above. A total of 750 ng of DNA was digested overnight
byAflII and AhdI (NEB) at 37C in a total reaction volume of 30 mL. The resulting
fragments were separated by agarose gel (1%) electrophoresis (1 3 TAE),
denatured by alkaline treatment (0.4 N NaOH; 0.6 M NaCl; regeneration in
1.5 M NaCl; 0.5 Tris-HCl, pH 7.5), and subsequently transferred onto a nylon
membrane (Roche Diagnostics) with 20 3 SCS (3 M NaCl; 0.3 M sodium
citrate). Fixation was carried out by UV-cross-linking. A digoxigenin (DIG)-
labeled probe was produced by random PCR priming (PCR DIG probe
synthesis kit; Roche Diagnostics) of a 291 nt-long PCR-product (primer pair
MZ047/048; Table S3), specific for the upstream flanking region of the DNA
construct for the allelic replacement (Figure 2). For hybridization and immuno-
detection the DIG Easy Hyb wash and block buffer set and the CDP-Star solu-
tion (Roche Diagnostics) were used according to the manufacturer’s protocol.
Metabolic Comparison of S. aureusWT and KO
and other Staphylococcus Strains
A total of 150 ml of TSB was inoculated with a single colony of either the wild-
type or DpznA strain of S. aureus RN4220. After 24, 48, 72, and 90 hr, a 25 ml
aliquot was centrifuged at 5000 3 g for 30 min, and the resulting pellet and
supernatant were lyophilized. The dried samples were extracted by methanol,
filtered, evaporated under vacuum and redissolved in 1 ml methanol. One
hundred microliters of this sample was analyzed by RP-HPLC (System Gold,
Beckman) on aC18(2) Luna 5 mm100A 2503 10.00mmcolumn (Phenomenex)
with a linear gradient from 20% to 40% solvent B (acetonitrile) in solvent A
(0.1% trifluoroacetic acid/water) over 50 min, with a flow rate of 3.5 mL/min,
monitored at 200–600 nm (Figure 3). S. epidermidis ATCC 12228, S. epidermi-
dis ATCC 35984, and S. saprophyticus S41 were obtained from the ATCC and
analyzed in the same manner as S. aureus (Figure 3).
Isolation and Structure Elucidation of the Staphylococcus
Pyrazinones
TSB (4 3 1 L) was inoculated with 1 ml of an overnight culture (in TSB) of
S. aureus RN4220 WT and incubated at 37C and 220 RPM for 48 hr. The
culture supernatant was subjected to solid-phase extraction using four 10-g
C18 SepPak columns (Waters). The columns were washed with two column
volumes (CVs) of water and bound molecules were eluted with three CVs of
60% solvent B (acetonitrile) in solvent A (0.1% trifluoroacetic acid/water).
The eluted fraction was lyophilized, resolubilized in methanol, and chromato-
graphed using the RP-HPLC conditions described above. The peak at 42 min
corresponding to 2was collected (Figure 3), lyophilized, and further purified by
the following isocratic RP-HPLC conditions: C18(2) Luna 5 mm 100A 250 3
10.00 mm column (Phenomenex), 28% solvent B (acetonitrile) in solvent A
(0.1% trifluoroacetic acid/water), flow rate 3.5 mL/min.
For the production of 1 and 3, the biomass from TSB cultures was resus-
pended in 0.5 volumes of modified minimal medium MSgg (100 mM MOPS,
pH 7.0; 0.5% L-glutamate; 0.5% glycerol; 2.5 mM KH2PO4; 2.5 K2HPO4;
50 mM FeCl3; 2 mM MgCl2; 50 mM MnCl2; 1 mM ZnSO4; 0.7 mM CaCl2; 2 mM
thiamine), supplemented with valine and either tyrosine or leucine (each atChemistry & Biology 17, 925–91 mg/mL). After incubation for 36 hr at 37C and 220 rpm the culture superna-
tant was extracted three times with 0.6 volumes of ethyl acetate. The solvent
was evaporated under vacuum and the dry extract was resolubilized in meth-
anol for further separation by RP-HPLC as described above. The peaks at 22
and 32 min, corresponding to 1 and 3, respectively, were collected (Figure 3).
The leuvalin structure (3) was further purified using the same protocol as 2,
whereas the contents of acetonitrile was decreased to 20% for the isocratic
purification of the more polar 1.
High resolutionmasses of the isolated compounds were recorded by FT-MS
in themass spectroscopy service lab of theKeck Foundation at YaleUniversity.
H1-NMR spectra and 2D-experiments (gCOSY, gHSQC, and gHMBC) were
recorded following the standard protocols on a Varian 600 MHz NMR spec-
trometer. Data analysis was carried out with the VNMRJ software suite.
DMSO-d6 andCDCl3 (Cambridge Isotope Laboratories) were used as solvents.
Biosynthetic Analysis of the Staphylococcus Pyrazinones
The protocol described for the production of the Staphylococcus pyrazinones
in modified MSgg medium was applied for their labeling with stable iso-
topes. L-valine (D8), L-phenylalanine (Ring-D5), L-tyrosine (Ring-3,5-D2), and
L-leucine were purchased from Cambridge Isotope Laboratories. The total
culture volume was 100 ml and the compounds were extracted as described
above. The isolated peaks were analyzed by LC-MS (1100 Series Agilent and
esquire 3000 plus Bruker). The used column was a ZOROBAX 3.5 mm Extend
C18 2.1 3 50 mm (Agilent). A linear gradient from 1% to 99% acetonitrile with
0.1% formic acid was developed over 20 min. The chromatography wasmoni-
tored at 325 nm and masses between 50 and 2000 Da were recorded.
Bioactivity Assay
Corynebacterium accolens ATCC 49725 and Corynebacterium urealyticum
ATCC 43042 were obtained from the ATCC, Corynebacterium jeikeium
NCTC 11915 from the National Collection of Type Cultures (NCTC) andPropio-
nibacterium acnes (P. acnes) DSM16379 from theGermanCollection ofMicro-
organisms andCell Cultures (DSMZ).S. aureusUAMS1was kindly provided by
Katherine Lemon and Roberto Kolter (Harvard Medical School). Escherichia
coli (E. coli) and Bacillus subtilis (B. subtilis) were from lab stocks. Staphylo-
coccus spp., E. coli, and B. subtilis were cultured in TSB. Corynebacterium
spp. and P. acnes were cultured in Brain Heart Infusion supplemented with
1% Tween 80 (BHIT80).
Ten microliters of a stock solution of tyrvalin in methanol at a concentration
of 2.8 mg/mL was spotted on standard filter discs for antibiotic inhibition
assays (Waters). Erythromycin (1 mg/mL) in methanol served as a positive
control, and pure methanol was used as a negative control.
The tested strains were grown as overnight cultures at 37C in liquid culture
media (the corresponding solid growth medium without the addition of agar).
P. acnes was grown anaerobically for 5 days. All cultures were diluted to
104 and 100 ml were streaked on solid culture media with the aid of 3 mm
glass beads (Fisher brand). The air-dried filter papers were transferred on
top of the bacterial lawn, followed by an incubation at 37C and (under anaer-
obic conditions for P. acnes using a glove box by Coy Laboratories, MI).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three tables, and five figures, and can be found with this article online at
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